4
Changes in Ownership
TherapeuticsMD, Inc. Filed Acc 0001209191-22-060585
Interim CFO/CAO/VP of Finance sold 910 shares at $4.78 ($4,345)
- Interim CFO/CAO/VP of Finance acquired 3,476 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Donegan Michael C · Interim CFO/CAO/VP of Finance
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-06 | Exercise or conversion : show line 1 in the form | +2,300 | 4,288 | D | ||
| 2022-12-06 | Exercise or conversion : show line 2 in the form | +380 | 4,668 | D | ||
| 2022-12-06 | Exercise or conversion : show line 3 in the form | +534 | 5,202 | D | ||
| 2022-12-06 | Exercise or conversion : show line 4 in the form | +262 | 5,464 | D | ||
| 2022-12-06 | Sale : show line 5 in the form | −910 | $4.78 | $4,345 | 4,554 | D |
| Open-market sales · 910 sh · avg $4.78 · $4,345 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-12-06 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −2,300 | 0 | D |
| 2022-12-06 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −380 | 380 | D |
| 2022-12-06 | Exercise or conversion : show line 8 in the form Restricted Stock Units | −534 | 1,066 | D |
| 2022-12-06 | Exercise or conversion : show line 9 in the form Restricted Stock Units | −262 | 519 | D |
Loading xslF345X03/doc4.xml…